{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T03:46:19Z","timestamp":1783136779234,"version":"3.54.6"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To investigate whether combined continuous venovenous hemofiltration and hemoperfusion among paraquat-poisoned patients would improve survival.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Prospective, controlled interventional study over 4 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Single, tertiary, academic medical center.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>We recruited patients admitted to Shanghai Tenth People\u2019s Hospital within 48 hours after paraquat ingestion. Exclusions were under 14 years old, ingestion of paraquat with other toxicants, pregnant, a history of chronic pulmonary disease, psychosis, hyperthyroidism, or diabetes with impaired liver or renal function.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>All patients were assigned to receive continuous venovenous hemofiltration with hemoperfusion therapy (continuous venovenous hemofiltration group) and to receive conventional therapy (conventional group). The study outcomes were death from any cause within 90 days after paraquat ingestion and the frequencies of hypoxia, acute kidney injury, or adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Measurements and Main Results:<\/jats:title>\n            <jats:p>Of the 110 enrolled patients, 59 were assigned to continuous venovenous hemofiltration group and 51 to conventional group. The two groups had similar baseline demographics and clinical features. At 90 days after paraquat ingestion, 19 of 59 patients (32.2%) in the continuous venovenous hemofiltration group and 29 of 51 patients (56.9%) in the conventional group had died (hazard ratio, 0.43; 95% CI, 0.24\u20130.76; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.004). In multivariable Cox proportional hazard models controlling for baseline characteristics, combined continuous venovenous hemofiltration and hemoperfusion was independently associated with reduced risk of death compared with conventional therapy (adjusted hazard ratio, 0.35; 95% CI, 0.19\u20130.64; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001). Patients in the continuous venovenous hemofiltration group, as compared to the conventional group, had a reduced occurrence rate of hypoxia (40.7% vs 72.5%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.001) and of acute kidney injury (59.3% vs 78.4%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.03). Hypophosphatemia and thrombocytopenia were more common in the continuous venovenous hemofiltration group (<jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In patients with paraquat poisoning, treatment with combined continuous venovenous hemofiltration and hemoperfusion significantly improved 90-day survival rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ccm.0000000000002826","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T20:16:28Z","timestamp":1510085788000},"page":"100-107","source":"Crossref","is-referenced-by-count":56,"title":["Treatment Outcome of Combined Continuous Venovenous Hemofiltration and Hemoperfusion in Acute Paraquat Poisoning: A Prospective Controlled Trial"],"prefix":"10.1097","volume":"46","author":[{"given":"Changbin","family":"Li","sequence":"first","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayong","family":"Hu","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xue","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zisheng","family":"Ai","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxiang","family":"Song","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Liu","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Cheng","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Fan","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya","family":"Wang","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Peng","sequence":"additional","affiliation":[{"name":"Center for Nephrology and Clinical Metabolomics and Division of Nephrology and Rheumatology, Shanghai Tenth People\u2019s Hospital, Tongji University School of Medicine, Shanghai, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230728","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/10408440701669959","article-title":"Paraquat poisonings: Mechanisms of lung toxicity, clinical features, and treatment.","volume":"38","author":"Dinis-Oliveira","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"R2-20230728","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/ije\/dyv304","article-title":"Impact of paraquat regulation on suicide in South Korea.","volume":"45","author":"Cha","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R3-20230728","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2125.2011.04026.x","article-title":"Medical management of paraquat ingestion.","volume":"72","author":"Gawarammana","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"R4-20230728","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/qjmed\/hcp006","article-title":"Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration.","volume":"102","author":"Senarathna","year":"2009","journal-title":"QJM"},{"key":"R5-20230728","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/ajkd.2002.29880","article-title":"Failure of continuous venovenous hemofiltration to prevent death in paraquat poisoning.","volume":"39","author":"Koo","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R6-20230728","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1191\/0748233703th171oa","article-title":"Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo.","volume":"19","author":"Hong","year":"2003","journal-title":"Toxicol Ind Health"},{"key":"R7-20230728","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/096032719301200411","article-title":"Effect of aggressive haemoperfusion on the clinical course of patients with paraquat poisoning.","volume":"12","author":"Suzuki","year":"1993","journal-title":"Hum Exp Toxicol"},{"key":"R8-20230728","first-page":"14018","article-title":"Impact of Xuebijing and ulinastatin as assistance for hemoperfusion in treating acute paraquat poisoning.","volume":"8","author":"Shi","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R9-20230728","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thx.51.7.661","article-title":"Pulse therapy with cyclophosphamide and methylprednisolone in patients with moderate to severe paraquat poisoning: A preliminary report.","volume":"51","author":"Lin","year":"1996","journal-title":"Thorax"},{"key":"R10-20230728","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s001340100953","article-title":"Intermittent versus continuous renal replacement therapy in the ICU: Impact on electrolyte and acid-base balance.","volume":"27","author":"Uchino","year":"2001","journal-title":"Intensive Care Med"},{"key":"R11-20230728","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/15563658708992634","article-title":"Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient.","volume":"25","author":"Pond","year":"1987","journal-title":"J Toxicol Clin Toxicol"},{"key":"R12-20230728","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000445991","article-title":"Early stage blood purification for paraquat poisoning: A multicenter retrospective study.","volume":"42","author":"Li","year":"2016","journal-title":"Blood Purif"},{"key":"R13-20230728","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa010877","article-title":"Daily hemodialysis and the outcome of acute renal failure.","volume":"346","author":"Schiffl","year":"2002","journal-title":"N Engl J Med"},{"key":"R14-20230728","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/ki.2013.378","article-title":"Reading between the (guide)lines\u2013the KDIGO practice guideline on acute kidney injury in the individual patient.","volume":"85","author":"Okusa","year":"2014","journal-title":"Kidney Int"},{"key":"R15-20230728","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1164\/ajrccm.159.2.9803089","article-title":"A prospective clinical trial of pulse therapy with glucocorticoid and cyclophosphamide in moderate to severe paraquat-poisoned patients.","volume":"159","author":"Lin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R16-20230728","doi-asserted-by":"crossref","first-page":"e0121691","DOI":"10.1371\/journal.pone.0121691","article-title":"The volume ratio of ground glass opacity in early lung CT predicts mortality in acute paraquat poisoning.","volume":"10","author":"Kang","year":"2015","journal-title":"PLoS One"},{"key":"R17-20230728","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.neuroimage.2010.08.054","article-title":"Consumption of caloric and non-caloric versions of a soft drink differentially affects brain activation during tasting.","volume":"54","author":"Smeets","year":"2011","journal-title":"Neuroimage"},{"key":"R18-20230728","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1378\/chest.128.3.1506","article-title":"Clinical implications of the ethane in exhaled breath in patients with acute paraquat intoxication.","volume":"128","author":"Hong","year":"2005","journal-title":"Chest"},{"key":"R19-20230728","doi-asserted-by":"crossref","first-page":"e51743","DOI":"10.1371\/journal.pone.0051743","article-title":"Sequential organ failure assessment score can predict mortality in patients with paraquat intoxication.","volume":"7","author":"Weng","year":"2012","journal-title":"PLoS One"},{"key":"R20-20230728","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/15563659309000391","article-title":"Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog.","volume":"31","author":"Pond","year":"1993","journal-title":"J Toxicol Clin Toxicol"},{"key":"R21-20230728","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/096032719000900103","article-title":"Toxicokinetics of paraquat in humans.","volume":"9","author":"Houz\u00e9","year":"1990","journal-title":"Hum Exp Toxicol"},{"key":"R22-20230728","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0041-008X(81)90273-8","article-title":"Kinetics of paraquat elimination in the dog.","volume":"57","author":"Hawksworth","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"key":"R23-20230728","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1093\/ndt\/gfn615","article-title":"The clinical features of acute kidney injury in patients with acute paraquat intoxication.","volume":"24","author":"Kim","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R24-20230728","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.toxlet.2015.06.008","article-title":"Kidney damage biomarkers detect acute kidney injury but only functional markers predict mortality after paraquat ingestion.","volume":"237","author":"Mohamed","year":"2015","journal-title":"Toxicol Lett"},{"key":"R25-20230728","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0041-008X(79)90039-5","article-title":"The effect of paraquat and diquat on renal function in the rat.","volume":"48","author":"Lock","year":"1979","journal-title":"Toxicol Appl Pharmacol"},{"key":"R26-20230728","first-page":"64","article-title":"Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients.","volume":"3","author":"Hampson","year":"1988","journal-title":"Med Toxicol Adverse Drug Exp"},{"key":"R27-20230728","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0140-6736(79)90345-3","article-title":"Paraquat poisoning: Significance of plasma-paraquat concentrations.","volume":"2","author":"Proudfoot","year":"1979","journal-title":"Lancet"},{"key":"R28-20230728","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/096032718700600106","article-title":"Paraquat poisoning: The rationale for current treatment regimes.","volume":"6","author":"Davies","year":"1987","journal-title":"Hum Toxicol"},{"key":"R29-20230728","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/15563650701549403","article-title":"Association between plasma paraquat level and outcome of paraquat poisoning in 375 paraquat poisoning patients.","volume":"46","author":"Gil","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"R30-20230728","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0300060514549782","article-title":"Early haemoperfusion with continuous venovenous haemofiltration improves survival of acute paraquat-poisoned patients.","volume":"43","author":"Gao","year":"2015","journal-title":"J Int Med Res"},{"key":"R31-20230728","doi-asserted-by":"crossref","first-page":"e87568","DOI":"10.1371\/journal.pone.0087568","article-title":"Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: A nationwide study.","volume":"9","author":"Wu","year":"2014","journal-title":"PLoS One"},{"key":"R32-20230728","doi-asserted-by":"crossref","first-page":"e0123504","DOI":"10.1371\/journal.pone.0123504","article-title":"Traditional chinese medicine Xuebijing treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning.","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"R33-20230728","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","article-title":"Intensity of continuous renal-replacement therapy in critically ill patients.","volume":"361","author":"Bellomo","year":"2009","journal-title":"N Engl J Med"},{"key":"R34-20230728","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.3109\/0886022X.2015.1057799","article-title":"The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.","volume":"37","author":"Ferreira","year":"2015","journal-title":"Ren Fail"},{"key":"R35-20230728","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.2215\/CJN.01280214","article-title":"Regional citrate anticoagulation for RRTs in critically ill patients with AKI.","volume":"9","author":"Morabito","year":"2014","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003246-201801000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T07:06:01Z","timestamp":1690527961000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003246-201801000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/ccm.0000000000002826","relation":{},"ISSN":["0090-3493"],"issn-type":[{"value":"0090-3493","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}